Off-label uses of drugs for depression

被引:33
|
作者
Skanland, Sigrid S. [1 ,2 ,3 ]
Cieslar-Pobuda, Artur [1 ,3 ,4 ]
机构
[1] Oslo Univ Hosp, Inst Canc Res, Dept Canc Immunol, Oslo, Norway
[2] Univ Oslo, KG Jebsen Ctr B Cell Malignancies, Inst Clin Med, Oslo, Norway
[3] Univ Oslo, KG Jebsen Ctr Canc Immunotherapy, Inst Clin Med, Oslo, Norway
[4] Univ Oslo, Ctr Mol Med Norway NCMM, Nordic EMBL Partnership, Oslo, Norway
关键词
Antidepressants; Chronic pain; Eating disorders; Off-label; Sleep disorders; Smoking cessation; MENOPAUSAL VASOMOTOR SYMPTOMS; PERIPHERAL NEUROPATHIC PAIN; SUSTAINED-RELEASE BUPROPION; HOT FLASHES; PHARMACOLOGICAL-TREATMENT; ANOREXIA-NERVOSA; PREMATURE EJACULATION; PSYCHIATRIC-DISORDERS; MIGRAINE PROPHYLAXIS; NICOTINE WITHDRAWAL;
D O I
10.1016/j.ejphar.2019.172732
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The prescription of drugs for depression is rising rapidly. One of the reasons for this trend is their many off-label uses. Up to one third of all prescriptions are for non-indicated use, which in addition to drug repurposing includes different dosing or duration than those recommended. In this review, we elaborate on what antidepressants can treat besides depression. The five classes of drugs for depression are introduced, and their mechanisms of action and serious side effects are described. The most common off-label uses of antidepressants are discussed, with a special focus on treating eating disorders, sleep problems, smoking cessation and managing chronic pain. Depression is often a comorbidity when antidepressants are chosen as therapy, but good therapeutic effects have been observed for other conditions also when depression is not involved. Finally, a new type of antidepressant developed from the hallucinogenic "party drug" ketamine is briefly introduced. This recent development suggests that antidepressants will keep playing a central role in medicine for years to come.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Off-label uses of alvimopan and methylnaltrexone
    Rodriguez, Ryan W.
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2014, 71 (17) : 1450 - 1455
  • [22] Off-label uses of trazodone: a review
    Bossini, Letizia
    Casolaro, Ilaria
    Koukouna, Despoina
    Cecchini, Federica
    Fagiolini, Andrea
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2012, 13 (12) : 1707 - 1717
  • [23] Off-label Uses of Topical Pimecrolimus
    Ladda, Matthew
    Sandhu, Vijay
    Ighani, Arvin
    Yeung, Jensen
    [J]. JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2019, 23 (04) : 442 - 448
  • [24] Off-Label Uses of Rituximab in Dermatology
    Connor Cole
    Kyle T. Amber
    [J]. Current Dermatology Reports, 2022, 11 : 209 - 220
  • [25] The use of "off-label"' drugs
    Broadman, LM
    Semenov, I
    [J]. ANESTHESIA AND ANALGESIA, 2006, 103 (01): : 250 - 251
  • [26] Off-label uses of rituximab in dermatology
    Carr, David R.
    Heffernan, Michael P.
    [J]. DERMATOLOGIC THERAPY, 2007, 20 (04) : 277 - 287
  • [27] Promotion of Drugs for Off-label Uses The US Food and Drug Administration at a Crossroads
    Kim, Jeanie
    Kapczynski, Amy
    [J]. JAMA INTERNAL MEDICINE, 2017, 177 (02) : 157 - 158
  • [28] Ivabradine: A Review of Labeled and Off-Label Uses
    Oliphant, Carrie S.
    Owens, Ryan E.
    Bolorunduro, Oluwaseyi B.
    Jha, Sunil K.
    [J]. AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2016, 16 (05) : 337 - 347
  • [29] Questions to Ponder Concerning Off-Label Uses
    John C. Hansen
    [J]. Drug information journal : DIJ / Drug Information Association, 1998, 32 (2): : 383 - 384
  • [30] Questions to ponder concerning off-label uses
    Hansen, JC
    [J]. DRUG INFORMATION JOURNAL, 1998, 32 (02): : 383 - 384